HCV in Pregnant Women – How the Opioid Crisis is Changing the Landscape | December 8, 2020

HCV in Pregnant Women – How the Opioid Crisis is Changing the Landscape | December 8, 2020

In this presentation, Kimberly Page, PhD, MPH, Professor of Epidemiology at The University of New Mexico, describes overall HCV infection trajectory in the US and shares trends seen in HCV… […]

Read More… from HCV in Pregnant Women – How the Opioid Crisis is Changing the Landscape | December 8, 2020

Medications for Opioid Use Disorder: Who Should Get What When? | January 16, 2020

Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, compares methadone, buprenorphine, and extended release naltrexone in terms of efficacy on a stable dose, induction, retention,… […]

Read More… from Medications for Opioid Use Disorder: Who Should Get What When? | January 16, 2020

Siletz Community Health Clinic: Implementing a Medication-Assisted Treatment (MAT) Program | June 6, 2019

Lisa Taylor, a family nurse practitioner at Siletz Community Health Clinic, shares the story of the Siletz Community Health Clinic in creating a medication-assisted treatment program to combat the opioid… […]

Read More… from Siletz Community Health Clinic: Implementing a Medication-Assisted Treatment (MAT) Program | June 6, 2019

HCV in Pregnant Women: How the Opioid Crisis is Changing the Landscape | September 26, 2018

Dr. Francheska Sevy Gurule, a Maternal Child Health Fellow at the University of New Mexico, Department of Family and Community Medicine, presents on the impact the opioid crisis has had… […]

Read More… from HCV in Pregnant Women: How the Opioid Crisis is Changing the Landscape | September 26, 2018